C linical and subclinical human papillomavirus (HPV) infections are among the most common sexually transmitted diseases today. 1 Asymptomatic HPV infections can be detected in 5% to 40% of women of reproductive age. 1 It is recognized that HPV infection is the central causal factor in cervical cancer. 1, 2 There are over 100 HPV types. At least 40 types infect the female and male anogenital tracts producing a spectrum of lesions ranging from genital condyloma to invasive cancer.
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Classification of HPV types
Based on their association with benign lesions, highgrade precursor lesions and invasive cancer, the anogenital HPV types can be classified into non-oncogenic and oncogenic risk categories. Low or non-oncogenic risk viruses include types 6,11,42,43,44 and they are associated with condylomata and some cases of low grade squamous intraepithelial lesions (CIN I) but rarely if ever invasive cancer. As a single oncogenic risk, type 16 is the most common one found in screening, high-grade (CIN II-III) squamous intraepithelial neoplasia and cancer. 2, 4, 5 Using PCR-based tests, 99.7% of cervical cancers worldwide are positive for HPV. 6 Viral types 16 and 18 predominate in glandular lesions (adenocarcinoma in situ and adenocarcinoma) with type 18 being the most common in adenocarcinoma and type 16 in adenocarcinoma in situ lesions. 7, 8 
Squamous intraepithelial neoplasia
There is an increased incidence of cervical squamous intraepithelial lesions and a higher prevalence of oncogenic HPVs in human immunodeficiency virus (HIV) infected women because of CD4 T-cell suppression and viral load in both adolescents and adults [9] [10] [11] [12] [13] Persistent squamous intraepithelial lesions occur more often in HIV-infected women probably because of immunosuppression (CD 4 count ≤ 200 cells/mm 3 ). [9] [10] [11] [12] [13] High risk type HPV infections of the cervix and vagina are transient in 80% of women. In these cases an intraepithelial lesion does not develop and the virus clears in 6 to 8 months. 14, 15 Intraepithelial neoplasia will develop in the other 20% of women but the high majority of these will similarly regress, the virus clears and the lesion subsequently disappears. 4, [14] [15] [16] Peak levels of high risk viral types (prevalence 20 to 25%) occur in women between 20 to 24 years of age. 2, 4 It is estimated that between 5% and 10% of low-grade squamous intraepithelial lesions progress to high-grade squamous intraepithelial lesions and rarely to cancer. 17, 18 In contrast 30% of untreated high-grade lesions of the cervix progress to invasive cancer. 19 The progression of a lowgrade lesion is thought to be due to the presence of an oncogenic viral type -specifically types 16 and 18. This suggests that HPV typing may be useful in predicting the likelihood of progression and the necessity of treating. 20, 21 Because few low-grade intraepithelial lesions (cervical intraepithelial neoplasia grade 1/CIN I) progress, many clinicians choose not to treat them but only to follow patients with cytology, colposcopy and at times biopsy. Any advancement in lesion grade requires treatment. Such candidates are usually young and nulliparous. CO 2 laser ablation and cryosurgery are excellent options with cure rates exceeding 90%. 22 Electrosurgical loop excision is another option. Since highgrade squamous intraepithelial lesions(including moderate dysplasia/CIN II and severe dysplasia/carcinoma in situ/CIN III) can progress to malignancy, treatment is recommended.
What is the best method of treatment?
Currently many investigators advocate electrosurgical loop excision for ectocervical high-grade squamous intraepithelial lesions. [23] [24] [25] This is a retreat from the widespread practice in the last 20 years of ablation by cryosurgery, carbon dioxide laser vaporization, electrodiathermy and cold-coagulation. Most are office procedures and some require brief anesthesia. All ablative procedures rely on adequate colposcopic evaluation and correlation to assure that invasive cancer is not missed. Patients are cured using these techniques in 98% of cases with one or two procedures. 22, [26] [27] [28] [29] [30] The purported advantage of routine excision of colposcopically defined high-grade squamous intraepithelial neoplasia is that a specimen (or specimens) is always available. However, the following questions apply: a) is the specimen(s) always interpretable?; b) when interpretable is cancer ever missed?; c) do clear margins insure that no high-grade lesion or cancer is present?, and d) does the thermal effect interfere with interpretation of clear margins or with a diagnosis of adenocarcinoma?
At colposcopic examination one determines whether the examination is satisfactory or not and formulates a colposcopic impression. After the correlation process has been completed, the colposcopist must determine what the patient needs next. Is it: a) referral to a gynecologic oncologist for staging; b) diagnostic excision (conization); c) conservative local treatment, or d) follow-up?
The indications for ablative methods or loop excision are: a) cytology, colposcopy, and pathology must correlate to establish an accurate tissue diagnosis; b) the entire transformation zone must be colposcopically defined; c) the colposcopist must be certain from the qualitative assessment of the transformation zone that no invasive cancer is present; d) the intraepithelial lesion must occupy the ectocervix with no extension into the endocervical canal, and e) preferably the patient is not pregnant. 30 In contrast excisional procedures are required when: a) discrepancies exist between cytology, colposcopy and histology; b) significant lesions are located in the endocervical canal and require tissue for histological sampling; c) cytology or colposcopy suggests possible invasive carcinoma that has not been proven by colposcopically directed biopsy; d) colposcopic biopsy indicates microinvasive squamous disease or adenocarcinoma in situ, or e) when colposcopy is unsatisfactory. 30 In these cases loop electrosurgery is not considered appropriate because the apical margin might be positive and electric current can interfere with histological interpretation. Laser excision or electrosurgical needle excision, removing a cylindrical specimen, with the apex of the specimen being cut with a scalpel or scissors (creating no thermal effect) produces a good quality specimen in the author's experience. 30 However, in these situations, some pathologists prefer the use of the scalpel and doing a cold knife conization. 31 In managing cervical intraepithelial lesions, regardless of method, the following must be taken into consideration in designing the excision parameters: a) intraepithelial neoplasia (particularly CIN III /severe dysplasia/carcinoma in situ) can extend into cervical crypts up to 5.2mm 32, 33 -it has been postulated that destruction/excision of lesions to a depth of 3.8 mm would eradicate all involved crypts in 99.7% of patients; 32 b) the radial linear length of squamous intraepithelial neoplasia varies between 2 and 22 mm (Figure 1) , 33, 34 and c) invasive cancer typically occurs on the canal side-that is, the worst pathology is locat-
FIGURE 1. A LARGE COMPLEX DENSELY ACETOWHITE CIN III APPEARING LESION EXTENDS INTO THE ENDOCERVICAL CANAL (UNSATISFACTORY COLPOSCOPY) WITH A LONG LINEAR LENGTH. THIS LESION REQUIRES CENTRAL EXCISION TO EXCLUDE CANAL MALIGNANCY SINCE THE WORST DISEASE (CANCER) POTENTIALLY LIES CENTRALLY
ed centrally. 35, 36 Therefore, accepting the known dimensions, to remove the likely diseased tissue with the least volume of normal tissue, one can conceptualize the three-dimensional geometry of disease in any given patient depending on the location of the squamocolumnar junction. Then appropriate operative techniques can be applied to remove or destroy it ( Figure  2) . 37 This is the basis of ablating or removing diseased tissue in a cylindrical manner or combining excision with ablation (the combination procedure) whether using central excision plus peripheral vaporization or electrosurgery with a combination of loop excisions or using the electrosurgical needle ( Figures 3 and 4) .
Treatment, especially by excisional methods, can cause symptomatic stenosis with canal narrowing, although this is an infrequent complication. The most common patient symptom is severe dysmenorrhea. Narrowing can lead to difficulty in obtaining satisfactory cytology. 38, 39 Stenosis is related to hypoestrogenic states: a) women of reproductive age with oligomenorrhea or amenorrhea; b) women on a low-dosage contraceptive pill who have oligomenorrhea or amenorrhea; c) women who are post-partum and lactating; d) post-menopausal women who are not on hormone replacement therapy with amenorrhea; e) women who are on estrogen and progesterone therapy with amenorrhea, and f) medroxyprogesterone acetate patients.
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The incidence of cervical stenosis can be reduced by the use of cyclic conjugated estrogen and progesterone to induce menses before and after treatment for several months. 39 Long length (height) of the specimen (≥20mm) and an entirely endocervical lesion appear to be independent risk factors for stenosis. 38 The majority of cervical stenosis cases (95%) are diagnosed at the first post-operative assessment and are usually easily treated by dilation of the endocervical canal. 38 When thermal energy is used, heat may interfere with accurate histological interpretation. Some investigators found loop specimens in general difficult to interpret due to the thermal artifact and fragmentation. This interfered with margin assessment and grading of the lesion. [40] [41] [42] In contrast, others experienced no difficulties in specimen assessment.
43, 44 Furthermore, unrecognized malignancy has been identified in hysterectomy specimens (a surprise finding) following loop excision. 45 Regardless of the method of treatment persistent disease occurs. After ablative methods it is usually identified at the first visit by colposcopy using acetic acid and iodine staining and including cytology. 30 No earlier than three months after treatment the patient is submitted to the standard colposcopic examination with biopsies (including endocervical curettage) if warranted. If significant disease is identified, retreatment is usually necessary. The technique depends upon disease location. For excisional procedures, it is important to know whether there was an endocervical (apical) margin positive or an ectocervical margin positive. This is because a positive endocervical margin with CIN III disease can signal potential remaining cancer in 3 to 8% in the intact cervix (potentially, the worst disease occurs centrally). [46] [47] [48] [49] [50] In excisional procedures the reporting of negative margins is associated with a 90 to 97% normal follow-up 51 versus a 60 to 65% persistent disease rate with positive margins and positive endocervical curettage (ECC) -the ECC being done immediately after the conization. 51, 52 That is, a histological report of incomplete excision of cervical dyspla- Figure 5 illustrates an algorithm to investigate persistent disease after conservative management. Despite negative margins and normal follow-up there is a small lifetime risk of developing an invasive cancer in the intact cervix of 2 to 4%. 53, 54 In some cases simple hysterectomy for the highgrade squamous case may still be required for the following reasons: a) failed conservative management; b) extensive disease involving the cervix and vagina where conservative management may be difficult; c) the presence of co-existing pathology (not resolved conservatively) such as large fibroids, uterine prolapse, endometriosis or intractable menorrhagia; d) technical difficulties in exposure; e) unresolved post-conservative treatment stenosis; f) definitive management of adenocarcinoma in situ; g) to control hemorrhage post-excision (conization), and h) cancer phobia. 54 If a hysterectomy is done for some reason, invasive cancer still develops in the vaginal vault in 0.1 to 2.0% of cases. [53] [54] [55] [56] Reprinted with permission from: Wright VC, Lickrish G, Shier RM. Basic and Advanced Colposcopy, Part Two: A Practical Handbook for Treatment (2 nd ed.). Houston: Biomedical Communications, 1995
Cervical adenocarcinoma in situ
Adenocarcinoma in situ (AIS) of the uterine cervix was first described in 1953 by Freidel and McKay. 57 Glandular lesions have a morphological spectrum (similar to squamous) ranging from mild changes to severe abnormalities termed cervical intraepithelial glandular neoplasia and abbreviated as CIGN, CGIN or GIN. This spectrum has been divided into low grade and high grade CIGN. 58, 59 In this article the specific entity AIS (high grade CIGN) will be discussed.
Adenocarcinoma in situ is uncommon. The ratio of AIS to CIN III lesions (severe dysplasia/carcinoma) is 1:50 or 2%. [60] [61] [62] The majority of AIS cases (46 to 72%) contain a counterpart squamous component -termed "mixed disease"-which is usually a CIN III lesion. [61] [62] [63] Furthermore, AIS is less commonly diagnosed than its malignant counterpart, the latter accounting for 6 to 18% of all invasive cancers. 61, 64, 65 The usual age range of women with AIS is from 29 to 46 years with an average age of 35.8 years. 59, 65 Making the diagnosis of AIS by the clinician is challenging. The lesion is frequently overlooked because of the absence of clinical findings, the presence of normal cytology or cytology reflecting squamous disease and unfamiliar colposcopic patterns. 37, 66, 67 Cullimore et al noted that women with pure AIS were 4.8 years older than women with mixed disease. This finding suggests that cytologic studies are more accurate in identifying the squamous component than the glandular component. 59 Only recently have authors drawn attention to the colposcopic features suggestive of AIS. [68] [69] [70] The relative infrequency of AIS cases as compared to squamous disease has not permitted most physicians to accumulate large series or gain experience with colposcopic identification.
Basically there are three colposcopic presentations of AIS lesions. The most common colposcopic appearance is a papillary expression resembling an immature transformation zone ( Figure 6 ). Second is a flat, variegated red and white area resembling an immature transformation zone (Figure 7) . The least common is one or more isolated, elevated, individual, densely acetowhite lesions overlying columnar epithelium. [68] [69] [70] When glandular and squamous lesions coexist, the squamous component is more likely to be noted because it is more likely visible. In mixed disease, the glandular lesion can abut the glandular lesion, be sandwiched between two squamous lesions or lie above the squamous lesion (Figure 8) . 68, 69 There is no single colposcopic appearance which characterizes adenocarcinoma in situ. In many cases colposcopic appearances of AIS mimic other conditions (Table I) .
AIS lesions can be small, focal and easily missed. 17, 59 Ectocervical expression occurs in 53% of cases, the endocervical canal in 5% of cases and contiguous involvement in 38%, indicating that 95% of AIS cases are available for partial or complete colposcopic scrutiny. 71 Forty-eight percent of lesions involve one quadrant whereas only 10% occupy all four. 71 Measurements (linear length) of AIS lesions (the distance over the tissue surface between caudal and cephalad edges) have been studied. The distance usually does not exceed 15 mm and rarely does it encompass the entire glandular epithelium. 17, 72, 73 Younger women, particularly those less than age 36 years, have a significant reduction in the proximal extent of AIS. Nicklin et al found that women younger than age 36 years have a mean lesion length of 5.6 mm, versus 10.8 mm for women age 36 years and older (a statistically significant difference). 72 Only 1 of 14 younger women from a series of 31 patients, had a linear length of more than 10 mm. In contrast 9 of 17 women in the older group had lesion lengths of more than 10 mm, with a maximum of 25 mm. 72 Bertrand et al studied the highest focus of cervical involvement of AIS measured from the maximal convexity of the cervix in hysterectomy specimens. The highest focus did not exceed 19.9 mm in 78.9% of cases, the highest focus being 29.9 mm. 74 Such measurements however do not reflect the true linear length of disease but rather provide guidelines for designing cylindrical excisional specimen measurements to account for the distribution particularly for endocervical canal involvement.
As in squamous intraepithelial neoplasia, AIS can extend into underlying cervical crypts. Involvement averages 2.5 mm and extension is usually no more than 4 mm, maximum 6 mm. 37, 63, 72, 73 Also younger women (age 35 or less) had a lesser depth of disease than did older women. 72 Multifocal lesions (so called "skip lesions") represent foci involving different portions of the endocervical mucosa. By definition, this is when a normal radial histological section separates two areas of AIS. 74 Such lesions are uncommon and occur in 6.5 to 15% of AIS lesions. 17, 74 Multifocality of AIS does not appear to correlate with a higher incidence of residual disease. 31 AIS can involve both superficial and deep crypts that are covered by metaplastic or dysplastic squamous epithelium. This is termed "buried disease" and occurs in 60% of cases. 63, 74 Although the crypts open through such tissue, the glandular component will not be colposcopically visible.
AIS lesions are to be suspected when any of the following colposcopic findings are observed: a) a lesion overlying columnar epithelium and not conti- guous with the squamocolumnar junction; b) large gland openings ( Figure 7) ; c) papillary-like lesions (Figure 6) ; d) epithelial budding; e) variegated red and white lesions (Figure 7) , and f) atypical angioarchitecture such as waste-thread-like, tendril-like, root-like (Figure 8 ) or character-writing-like vessels and single and multiple-dot-like formations (Figure 6 ), the latter seen in the tips of the papillary excrescences. The differential of similar appearing lesions is shown in Table I . 68 Having suspected the glandular lesion, the clinician should consider the following in AIS management: a) patient's age; b) lesion location (ectocervical, endocervical, or both -colposcopic assessment can be helpful); c) three dimensional lesion geometry (linear length and crypt involvement); d) potential for buried disease; e) mixed disease (presence of a squamous component); f) specimen margin status post-excision; g) patient's desire for fertility, and h) patient's compliance.
When AIS is found on biopsy or suspected cytologically or colposcopically, an excisional procedure is required, producing a specimen with negative margins (ie, free of disease) -the latter to help ensure that no adenocarcinoma is present. The excisional procedure should attempt to account for the distribution of disease (linear length, crypt involvement, and disease location). As in squamous intraepithelial neoplasia, the configuration (base and height dimensions) will vary. A cylindrical shaped specimen best accounts for disease distribution (Figure 9) . 63, 74, 75 It is recommended that the procedure be done under colposcopic guidance noting the lower lesion border (which is usually at or very near the squamocolumnar junction), and if possible, noting or estimating the upper margin, that is, the entire potential linear length. 63, 74, 75 These parameters ification or streaming of nuclei parallel to the electric field) making it difficult to histologically differentiate between in situ and invasive disease. 37, 77 Furthermore such loop specimens are often fragmented due to several passes making evaluation of the margins difficult. 37 Others have found that the use of loop excision in the management of AIS is acceptable when there is a single specimen with clear margins. 78 Cumulative studies show that positive margins are of significance due to persistent AIS in 12.5 to 80% of cases. 59, 60, 71, 72, [79] [80] [81] [82] [83] [84] [85] [86] Adenocarcinoma is found in 12.5 to 50% of such cases. 71, 80, 82 Other studies did not identify malignancy (adenocarcinoma) in cases with positive margins on follow-up histology. 17, 59, [71] [72] [73] 81, 83, 84 In positive margin cases, repeat excision is recommended to obtain negative margins in the conservatively managed patient who desires future childbearing. Repeat excision, producing negative margins is also recomserve as a guide for determining the dimensions of the cylindrical specimen.
The preferred instrument for the excisional procedure to provide the best interpretable specimen is a subject of debate. From the pathologist's standpoint, the cold knife conization is the safest and best therapeutic modality, provided that the cone specimen is adequately sampled and the margins are free. 37, 76 Other investigators have found that the use of laser or electrosurgical needle to create the deep margin plus scalpel excision of the cylinder's apex (producing a non-thermal effect) to be satisfactory. 75 It must be recognized that a cold knife conization can be a formidable operation. There is general consensus that electrosurgical loop may not be the procedure of choice. This is because electric current follows the path of least resistance (into crypt mucus) and thus it can potentially distort the glandular epithelium (causing pseudostrat- mended before a simple hysterectomy as definitive treatment. Failure to do so may result in inappropriate surgery (simple hysterectomy instead of radical hysterectomy), should adenocarcinoma be found in the extirpated uterine cervix. 75 Studies indicate that if excised specimens have negative margins then conservative management is possible in those women who desire future child bearing. 59, 71, 73, 82, 86 However, negative margins are associated with persistent AIS in 8.3 to 50% of cases. 71, [80] [81] [82] [83] [84] [85] [86] These findings suggest that cervical conization should not necessarily be considered a definitive treatment for AIS in the presence of negative margins. 30 Studies have rarely identified adenocarcinoma even when specimens had negative margins. 79, 80, 87 For the conservatively managed patient, followup management should consist of cytology, colposcopy, and endocervical curettage every four months for one year and every six months thereafter. 80, 87 Patients who choose to be followed conservatively must be counseled about the importance of compliance and the potential risks of undetected and recurrent glandular disease, despite negative follow-up findings. 79, 81 
